Research Context
Apex Cagri was developed as a synthetic analogue of amylin, a naturally occurring peptide hormone co-secreted with insulin by pancreatic beta cells. Research into Cagri has primarily focused on its ability to regulate appetite signaling pathways, delay gastric emptying, and influence energy balance. Investigations in metabolic disease models have explored its potential benefits in obesity and related metabolic disorders.
Its mechanism of action involves activation of amylin receptors within the central nervous system, particularly in regions associated with satiety and food intake regulation. Ongoing research aims to better understand its pharmacological effects, long-term metabolic implications, and potential synergistic effects when combined with other investigational compounds.
For research use only. Not for human or animal consumption.
| Size | 5MG, 10MG |
|---|
